Abstract:Objective To evaluate the accuracy, of different threshold segmentation of 18FDG PET for target volume delineation of non-small cell lung cancer(NSCLC) and the potential influence on radiotherapy treatment planning. Methods Eight NSCLC patients who had tumor with clear margin on CT scan and the amplitude of tumor movements not more than 5 mm were enrolled. PET scans were carried out at 1 h after intravenous injection of 18FDG with CT image for attenuation revisement. Gross target volume (GTV) delineated on CT image ( GTVCT ) was used as the standard. Then, GTVs were delineated on PET image with three different threshold segmentation of 42% Imax(total) (42% of maximum voxel intensity within the tumor) ,Iback + 20% Imax-back(max) (mean background intensity + 20% of normalized background-subtracted maximum voxel intensity within the tumor) and Iback -20% Imax-back(slice) (mean background intensity + 20% of normalized background-subtracted maximum voxel intensity of each slice within the tumor) ,the corresponding GTV was named as GTV42%, GTV20%max and GTV20%slice. Both the size of GTV42%, GTV20%max, GTV20%slice and GTVCT,and the coverage over GTVCT for each GTV were compared. A three dimensional margin of 1 cm were added to GTVCT, GTV42%, GTV20%max and GTV20%slice to form corresponding PTVCT, PTV42%, PTV20%max and PTV20%slic e. Three dimensional conformal radiotherapy treatment plans were designed based on PTVCT,PTV42% , PTV20%max and PTV20%slice respectively for each patient. The prescription dose of all PTVs was 66 Gy in 33 fractions in 6.6 weeks. Both the volume accepting dose less than 95% of prescription dose within PTVCT ( VPTV ) and the lung V20 were compared among the four plans based on different PTVs. Tumor control probability(TCP) as well as lung normal tissue complication probability (NTCP) were also compared. Resuits Eight patients were enrolled in this study. Median deviation of volume between GTVPET and GTVCT were -54.1% , -21.5 % and 5.3 % for GTV42% , GTV20%max and GTV20%slice, respectively. Median coverage over GTVCT of GTV42% , GTV20%max and GTV20%slice was 45.9% ,78.0% and 95.3% respectively( F = 57.50,P＜0.01). Median 7.5% of VPTV was observed for radiotherapy treatment plan based on PTV42% ,which meant that it might induce median 1% decrease of TCP comparing with that of radiotherapy treatment plan based on PTVCT. Whereas,there were only 1.3% and 0.0% of VPTV for treatment plans based on PTV20%max and PTV20%slice respectively. As far as TCP was concemed, both PTV20%max group and PTV20%slice group were superior to PTV42% group,there was no significant difference among PTV20%max group, PTV20%slice group and PTVCT group. Lung V20 and lung NTCP showed no significant difference among all groups. Conclusions The threshold segmentation of Iback + 20% Imax-back(slice) , being slice specialized, might be an optimal threshold segmentation for target volume delineation of lung caner. Independent of information of target volume provided by CT scan in advance,it is recommended to use for the target volume delineation of NSCLC with atelectasis.

Impact of gross tumor volume and radiation therapy dose on survival in stage Ⅲ non-small-cell lung cancer treated with three-dimensional radiation therapy

Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non-small cell lung cancer

A Prospective,multicenter,phase Ⅱclinical Study of Three-Dimensionalradiotherapy with Concurrent Chemotherapy for Stage IV Non-Small-cell Lung Cancer-the Impact of Different Pathological Types on Survival (PPRA-RTOG003)

Clinical Study on the Effect of Hypofractionated Three -Dimensional Conformal Radiation Therapy in the Treatment of Non -Small Cell Lung Cancer

Analysis of Treatment Outcome and Prognostic Factor with Three-Dimensional Conformal Radiotherapy for Thoracic Esophageal Squamous Cell Carcinoma

Prognosis of Three Dimensional Conformal Radiotherapy of Locally Advanced Non-small Cell Lung Cancer with Involved-field

Clinical Efficacy of CT-guided 125 I Radioactive Seeds Implantation for Stage Ⅲ of Non-Small Call Lung Cancer

The impact of tumor regression on the dose distribution of the three dimensional conformal radiotherapy for non-small cell lung cancer

Prediction of GTV/LV for radiation pneumonitis in patients with stage Ⅲ non-small cell lung cancer after radical radiotherapy

Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysis

The Prognostic Impact of Tumor Volume on Stage I Non-Small Cell Lung Cancer.

Clinical Study of Late-Course Three-Dimensional Conformal Radiotherapy for Esophageal Carcinoma

Risk factors for radiation pneumonitis in stage III non-small-cell lung cancer treated with three-dimensional conformal radiotherapy

Treatment results of radiotherapy for medically inoperable stage I/II non-small cell lung cancer

3-Dimensional conformal radiotherapy and paclitaxel radiosensitization combined with chemotherapy on locally advanced non-small cell lung cancer

A prospective, multicenter, phase II clinical study of three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small-cell lung cancer-PPRA-RTOG003

The impact of contrast CT scan on contouring of gross tumor volume of lung cancer in three-dimensional conformal radiation therapy

Impact of three threshold segmentation of 18FDG PET image on target volume delineation and radiotherapy treatment planning of non-small cell lung cancer

The Study of Tumor Volume As a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: an Exploratory Study.

Efficacy of the Smaller Target Volume for Stage III Non-Small Cell Lung Cancer Treated with Intensity-Modulated Radiotherapy.

Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer